Clinical Research Directory
Browse clinical research sites, groups, and studies.
Unmodified Versus Leuko-reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Summary
There is evidence to suggest that red blood cell concentrate (RBC) transfusion may have immunomodulatory effects. The aim of this randomized single-center trial is to compare immune responses in patients undergoing cancer surgery and given either an unmodified RBC (UN-RBC) or a leuko-reduced RBC (LR-RBC) transfusion perioperatively.
Official title: A Randomized Study of Unmodified Versus Leuko-reduced Allogeneic Red Blood Cells Transfusion During Surgery in Cancer Patients
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
1997-09
Completion Date
Not specified
Last Updated
2026-08-19
Healthy Volunteers
No
Interventions
transfusion of allogeneic red blood cell concentrate
transfusion of leuko-reduced red blood cell concentrate
Locations (1)
Institut Gustave Roussy
Villejuif, France